These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 13565952)

  • 1. [Clinical trials of mechlorethamine-N-oxide in therapy of tumors].
    SELLEI C; ECKHARDT A
    Munch Med Wochenschr; 1958 May; 100(19):784-6. PubMed ID: 13565952
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical studies on a cytostatic mannitol derivative (BCM)].
    ECKHARDT S; HARTAI F; MOLNAR E; SELLEI C
    Orv Hetil; 1956 Sep; 97(36):999-1001. PubMed ID: 13388313
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of neoplasms with a phenylalanine derivative of nitrogen mustard].
    ESTEVEZ RA; TRIMBOLI DE ESTEVEZ O
    Sem Med; 1958 Jan; 112(4):119-29. PubMed ID: 13556029
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical experiences with BCM (degranol) beta-bis-chlorethylamino-D-mannitoldichlorhydrate].
    ECKHARDT A; SELLEI C; MOLNAR A; HARTAI F
    Krebsarzt; 1958 Feb; 13(2):73-5. PubMed ID: 13540175
    [No Abstract]   [Full Text] [Related]  

  • 5. Mannomustine in treatment of leukaemias, polycythaemia, and malignant disorders.
    BARLOW AM; LEEMING JT; WILKINSON JF
    Br Med J; 1959 Aug; 2(5146):208-13. PubMed ID: 13671231
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical trials of a new nitrogen mustard, MX 101].
    IZARN P; POURQUIER H; GARY-BOBO J; PUJOL H; EMBERGER JM
    Montp Med; 1960 Nov; 58():178-83. PubMed ID: 13718407
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical observations with 1, 6-bis(beta-chloroethylamino)-1, 6-deoxy-D-mannitol dihydrochloride (BCM) in malignant diseases.
    SELLEI C; ECKHARDT S
    Ann N Y Acad Sci; 1958 Apr; 68(3):1164-80. PubMed ID: 13627769
    [No Abstract]   [Full Text] [Related]  

  • 8. [Disappearance of symptoms of granuloma fungoides after mustard mannitol (BCM) therapy].
    BAKOS L; VENKEI T
    Orv Hetil; 1957 Apr; 98(17):442. PubMed ID: 13452498
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapy of malignant diseases of the lymphatic and reticular systems with a nitrogen mustard derivative].
    ZULIK R
    Arzneimittelforschung; 1958 Jun; 8(6):360-1. PubMed ID: 13546105
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies of phenylalanine nitrogen mustard (CB 3025) in metastatic malignant melanoma of man.
    HOLLAND JF; REGELSON W
    Ann N Y Acad Sci; 1958 Apr; 68(3):1122-5. PubMed ID: 13627764
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical application to cancer chemotherapy of nitrogen-mustard N-oxide].
    KATSUNUMA S
    Gan; 1952 Sep; 43(2-3):174-5. PubMed ID: 12998802
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical studies on nitrogen mustard N-oxide].
    TASAKA S; TOMIZUKA Y; NITTA J; SHIKAMA S; KAZATO Y; OTANI A; TAMAKI T
    Gan; 1952 Sep; 43(2-3):169-71. PubMed ID: 12998800
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of melanoma by isolation-perfusion technique.
    CREECH O; RYAN RF; KREMENTZ ET
    J Am Med Assoc; 1959 Jan; 169(4):339-43. PubMed ID: 13610669
    [No Abstract]   [Full Text] [Related]  

  • 14. [Studies on the effects of nitrogen mustard oxide in cases of inoperable tumors].
    BECKER T
    Zentralbl Chir; 1957 May; 82(21):850-61. PubMed ID: 13457134
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical study of the antineoplastic effect of DL-p-bis(beta-chloroethyl) aminophenylalanine].
    DI PIETRO S
    Minerva Med; 1956 Aug; 47(63-64):340-2. PubMed ID: 13378179
    [No Abstract]   [Full Text] [Related]  

  • 16. Disseminated malignant melanoma: response to treatment by massive dosage of a cytotoxic agent combined with autogenous marrow replacement.
    WESTBURY G; HUMBLE JG; NEWTON KA; SKINNER ME; PEGG DE
    Lancet; 1959 May; 1(7080):968-9. PubMed ID: 13655649
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapeutic action of some derivatives of nitrogen mustard in malignant epithelial and connective tissue tumors].
    PRICOLO V; DI PIETRO S
    Tumori; 1951; 25(4):385-400. PubMed ID: 14901497
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pre- and post-operative dosage of degranol in operable cancer patients].
    RUBANYI P; SZEKELY J; NEMETH E
    Magy Seb; 1959 Mar; 12(1):65-8. PubMed ID: 13643065
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical experiences with nitrogen mustards. V. Therapy of malignant tumors].
    CERNIK F; LUKL P; PROCHAZKA J; VIZDA J
    Cas Lek Cesk; 1952 Jan; 91(2):44-9. PubMed ID: 14390080
    [No Abstract]   [Full Text] [Related]  

  • 20. [Results of treatment of malignant tumors with N-mustard gas-phosphamide ester (endoxan)].
    SCHWENKENBECHER W
    Ther Ggw; 1959 Jun; 98(6):285-7. PubMed ID: 13676100
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.